CGRP Antibodies for Animal Models of Primary and Secondary Headache Disorders

Pages: 69 - 97
Published: Jan 1, 2021
Abstract
As our understanding of the importance of calcitonin gene-related peptide (CGRP) in headache disorders has evolved, the therapeutic use of CGRP monoclonal antibodies has marked a new era in the headache field. Anti-CGRP antibodies that block either the ligand or the receptor are effective in the prevention of migraine and cluster headache. Nevertheless, there are still many uncertainties about mechanisms underlying the effects of CGRP and the...
Paper Details
Title
CGRP Antibodies for Animal Models of Primary and Secondary Headache Disorders
Published Date
Jan 1, 2021
Journal
Pages
69 - 97
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.